Clinical bottom line
Pulmonary arteriovenous malformations (PAVMs) present unique anesthetic challenges due to their potential for right-to-left shunting, hypoxemia, and paradoxical embolism during surgery or interventional procedures. Current evidence emphasizes careful preoperative assessment, vigilant intraoperative monitoring, and tailored anesthetic techniques to minimize complications. While data specific to anesthetic management in PAVMs remain limited, extrapolation from cerebral arteriovenous malformation (AVM) management and interventional radiology literature supports strategies to optimize oxygenation and hemodynamics. This evidence digest summarizes key considerations and highlights areas requiring further validation to guide anesthesiologists in managing patients with PAVMs undergoing surgery or embolization.
What the evidence shows
PAVMs are abnormal vascular communications between pulmonary arteries and veins, causing right-to-left shunting that can lead to hypoxemia, paradoxical emboli, and hemorrhage (Interventional Management of Pulmonary Arteriovenous Malformations, RadioGraphics 2025). The primary treatment is percutaneous embolization, often performed under general anesthesia or sedation, necessitating anesthetic vigilance to maintain oxygenation and prevent complications.
Anesthetic management principles for PAVMs are informed by the broader literature on AVMs and interventional neuroradiology. Manninen et al. (1995) describe anesthetic considerations for interventional neuroradiology procedures, emphasizing stable hemodynamics, avoidance of air embolism, and careful ventilation strategies to optimize oxygen delivery. Similarly, Teig Magnus Knut et al. (2021) highlight the importance of tailored anesthetic plans for patients undergoing intravascular treatment of cerebral AVMs, including meticulous blood pressure control and neuromonitoring to prevent hemorrhagic complications.
Although direct studies on PAVM anesthesia are sparse, imaging primers and interventional management reviews (RadioGraphics 2025) underscore the need for preoperative evaluation of shunt severity and pulmonary function. Hypoxemia from shunting may necessitate higher inspired oxygen fractions and avoidance of factors that increase pulmonary vascular resistance, such as hypoxia, hypercarbia, and acidosis. Intraoperative monitoring should include continuous pulse oximetry, arterial blood gases, and, when feasible, invasive hemodynamic monitoring to detect rapid changes.
High-flow AVMs, including PAVMs, pose risks of significant hemodynamic shifts during embolization. Young et al. (1994) discuss perioperative management of high-flow AVMs, recommending advanced hemodynamic monitoring and readiness to manage sudden changes in preload and afterload. Although focused on cerebral AVMs, these principles are applicable to PAVMs given similar vascular dynamics.
Neuromonitoring techniques described by Musahl et al. (2014) for AVM surgery may have limited direct applicability in PAVM embolization but highlight the value of monitoring end-organ perfusion and oxygenation during complex vascular interventions.
Caveats and uncertainty
The evidence base specific to anesthetic management of PAVMs is limited, with most guidance extrapolated from cerebral AVM and interventional neuroradiology literature. There is a lack of prospective clinical trials or large observational studies directly addressing anesthetic outcomes in PAVM patients. Variability in PAVM size, location, and shunt fraction complicates standardization of anesthetic protocols.
Furthermore, the optimal anesthetic agents and ventilation strategies to minimize right-to-left shunting and maintain oxygenation remain undefined. The impact of various anesthetic drugs on pulmonary vascular resistance in this population is not well characterized. The role of neuromonitoring beyond standard cardiorespiratory parameters is unclear.
Potential complications such as paradoxical air embolism, hemorrhage, and hypoxemia require vigilance but lack robust evidence-based prevention strategies tailored to PAVMs. Thus, current recommendations are largely hypothesis-generating and warrant validation in clinical studies.
How this may change practice
Anesthesiologists managing patients with PAVMs should incorporate thorough preoperative evaluation of pulmonary shunt severity and oxygenation status, ideally in collaboration with interventional radiology and pulmonology teams. Intraoperative management should prioritize:
- Avoidance of hypoxia, hypercarbia, and acidosis to reduce pulmonary vascular resistance and shunting.
- Use of high inspired oxygen concentrations and careful ventilation to optimize oxygen delivery.
- Vigilant monitoring including continuous pulse oximetry, arterial blood gases, and invasive hemodynamics when indicated.
- Preparedness for rapid hemodynamic changes during embolization, with appropriate vasoactive agents available.
- Minimization of air entrainment risk through meticulous intravenous line management.
Future research should focus on prospective studies evaluating anesthetic techniques, monitoring modalities, and outcomes in PAVM patients to develop evidence-based guidelines. Until then, anesthetic care remains individualized, guided by principles derived from related vascular malformation management.